Assessing tumor contrast in radiographically dense breast tissue using Diffuse Optical Spectroscopic Imaging (DOSI)

Breast Cancer Research

Volumn 15, Issue 5, 2013, Pages

  Leproux, Anaïs ^a   Durkin, Amanda ^a   Compton, Montana ^a   Cerussi, Albert E ^a   Gratton, Enrico ^b   Tromberg, Bruce J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYHEMOGLOBIN; LIPID; OXYHEMOGLOBIN; WATER; HEMOGLOBIN;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER DIAGNOSIS; CHROMATOPHORE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONCENTRATION (PARAMETERS); CONTRAST RADIOGRAPHY; CONTROLLED STUDY; DIFFUSE OPTICAL SPECTROSCOPIC IMAGING; FEMALE; HUMAN; IMAGE ANALYSIS; INFORMATION PROCESSING; INTRADUCTAL CARCINOMA; MAMMOGRAPHY; OPTICAL DENSITY; PILOT STUDY; RADIOLOGICAL PARAMETERS; RETROSPECTIVE STUDY; SPECTROSCOPY; SPECTRUM; TISSUE LEVEL; TUMOR VOLUME; BREAST TUMOR; CONGENITAL MALFORMATION; EQUIPMENT; FLUORESCENCE IMAGING; MAMMARY GLAND; MAMMOGRAPHIC DENSITY; METHODOLOGY; PATHOLOGY; RADIOGRAPHY; RISK FACTOR; BREAST AREOLA; BREAST CANCER; BREAST DENSITY; CLIMACTERIUM; DIODE LASER; MIDDLE AGED; ONCOLOGICAL PARAMETERS; POSTMENOPAUSE; PREMENOPAUSE; SPECIFIC TUMOR COMPONENT; TISSUE OPTICAL INDEX;

ADULT; BREAST NEOPLASMS; FEMALE; HUMANS; MAMMARY GLANDS, HUMAN; MAMMOGRAPHY; OPTICAL IMAGING; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84884578832     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr3485     Document Type: Article

References (43)

1. Hersh MR. Imaging the dense breast. Appl Radiol 2004, 33:22.
2. Buist DSM, Porter PL, Lehman C, Taplin SH, White E. Factors contributing to mammography failure in women aged 40-49 years. J Natl Cancer Inst 2004, 96:1432-1440. 10.1093/jnci/djh269, 15467032.
3. Bevers TB, Anderson BO, Bonaccio E, Buys S, Daly MB, Dempsey PJ, Farrar WB, Fleming I, Garber JE, Harris RE, Helvie M, Hoover S, Krontiras H, Shaw S, Singletary E, Sugg Skinner C, Smith ML, Tsangaris TN, Wiley EL, Williams C, . National Comprehensive Cancer Network Breast cancer screening and diagnosis. J Natl Compr Canc Netw 2009, 7:1060-1096. National Comprehensive Cancer Network.
4. Berg WA, Blume JD, Cormack JB, Mendelson EB, Lehrer D, Böhm-Vélez M, Pisano ED, Jong RA, Evans WP, Morton MJ, Mahoney MC, Larsen LH, Barr RG, Farria DM, Marques HS, Boparai K, . ACRIN 6666 Investigators Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA 2008, 299:2151-2163. 10.1001/jama.299.18.2151, 2718688, 18477782, ACRIN 6666 Investigators.
5. Mandelson MT, Oestreicher N, Porter PL, White D, Finder CA, Taplin SH, White E. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 2000, 92:1081-1087. 10.1093/jnci/92.13.1081, 10880551.
6. US Preventive Services Task Force Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009, 151:716-726. W-236. Erratum in: Ann Intern Med 2010, 152:688. Ann Intern Med 2010, 152:199-200, US Preventive Services Task Force.
7. Fredholm H, Eaker S, Frisell J, Holmberg L, Fredriksson I, Lindman H. Breast cancer in young women: poor survival despite intensive treatment. PLoS ONE 2009, 4:e7695. 10.1371/journal.pone.0007695, 2770847, 19907646.
8. Kelly K, Dean J, Comulada W, Lee S-J. Breast cancer detection using automated whole breast ultrasound and mammography in radiographically dense breasts. Eur Radiol 2010, 20:734-742. 10.1007/s00330-009-1588-y, 2822222, 19727744.
9. Kole AC, Nieweg OE, Pruim J, Hoekstra HJ, Koops HS, Roodenburg JL, Vaalburg W, Vermey A. Detection of unknown occult primary tumors using positron emission tomography. Cancer 1998, 82:1160-1166. 10.1002/(SICI)1097-0142(19980315)82:6<1160::AID-CNCR22>3.0.CO;2-3, 9506364.
10. Morris EA, Liberman L, Ballon DJ, Robson M, Abramson AF, Heerdt A, Dershaw DD. MRI of occult breast carcinoma in a high-risk population. Am J Roentgenol 2003, 181:619-626.
11. Crystal P, Strano SD, Shcharynski S, Koretz MJ. Using sonography to screen women with mammographically dense breasts. Am J Roentgenol 2003, 181:177-182.
12. Buchanan C, Morris E, Dorn P, Borgen P, Van Zee K. Utility of breast magnetic resonance imaging in patients with occult primary breast cancer. Ann Surg Oncol 2005, 12:1045-1053. 10.1245/ASO.2005.03.520, 16244803.
13. Pisano ED, Gatsonis C, Hendrick E, Yaffe M, Baum JK, Acharyya S, Conant EF, Fajardo LL, Bassett L, D'Orsi C, Jong R, Rebner M, . Digital Mammographic Imaging Screening Trial (DMIST) Investigators Group Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med 2005, 353:1773-1783. 10.1056/NEJMoa052911, 16169887, Digital Mammographic Imaging Screening Trial (DMIST) Investigators Group.
14. Schilling K, Narayanan D, Kalinyak J, The J, Velasquez M, Kahn S, Saady M, Mahal R, Chrystal L. Positron emission mammography in breast cancer presurgical planning: comparisons with magnetic resonance imaging. Eur J Nucl Med Mol Imaging 2011, 38:23-36. 10.1007/s00259-010-1588-9, 3005116, 20871992.
15. Taroni P, Torricelli A, Spinelli L, Pifferi A, Arpaia F, Danesini G, Cubeddu R. Time-resolved optical mammography between 637 and 985 nm: clinical study on the detection and identification of breast lesions. Phys Med Biol 2005, 50:2469-2488. 10.1088/0031-9155/50/11/003, 15901949.
16. Wang J, Jiang SD, Li ZZ, DiFlorio-Alexander RM, Barth RJ, Kaufman PA, Pogue BW, Paulsen KD. In vivo quantitative imaging of normal and cancerous breast tissue using broadband diffuse optical tomography. Med Phys 2010, 37:3715-3724. 10.1118/1.3455702, 2909301, 20831079.
17. Cerussi A, Shah N, Hsiang D, Durkin A, Butler J, Tromberg BJ. In vivo absorption, scattering, and physiologic properties of 58 malignant breast tumors determined by broadband diffuse optical spectroscopy. J Biomed Opt 2006, 11:044005. 10.1117/1.2337546, 16965162.
18. Choe R, Konecky SD, Corlu A, Lee K, Durduran T, Busch DR, Pathak S, Czerniecki BJ, Tchou J, Fraker DL, Demichele A, Chance B, Arridge SR, Schweiger M, Culver JP, Schnall MD, Putt ME, Rosen MA, Yodh AG. Differentiation of benign and malignant breast tumors by in-vivo three-dimensional parallel-plate diffuse optical tomography. J Biomed Opt 2009, 14:024020. 10.1117/1.3103325, 2782703, 19405750.
19. Colak SB, van der Mark MB, Hooft GW, Hoogenraad JH, van der Linden ES, Kuijpers FA. Clinical optical tomography and NIR spectroscopy for breast cancer detection. IEEE J Sel Top Quant 1999, 5:1143-1158.
20. Fang Q, Selb J, Carp SA, Boverman G, Miller EL, Brooks DH, Moore RH, Kopans DB, Boas DA. Combined optical and X-ray tomosynthesis breast imaging. Radiology 2011, 258:89-97. 10.1148/radiol.10082176, 3009384, 21062924.
21. Enfield LC, Gibson AP, Everdell NL, Delpy DT, Schweiger M, Arridge SR, Richardson C, Keshtgar M, Douek M, Hebden JC. Three-dimensional time-resolved optical mammography of the uncompressed breast. Appl Optics 2007, 46:3628-3638.
22. Leff DR, Warren OJ, Enfield LC, Gibson A, Athanasiou T, Patten DK, Hebden J, Yang GZ, Darzi A. Diffuse optical imaging of the healthy and diseased breast: A systematic review. Breast Cancer Res Treat 2008, 108:9-22. 10.1007/s10549-007-9582-z, 17468951.
23. Taroni P, Pifferi A, Quarto G, Spinelli L, Torricelli A, Abbate F, Villa A, Balestreri N, Menna S, Cassano E, Cubeddu R. Noninvasive assessment of breast cancer risk using time-resolved diffuse optical spectroscopy. J Biomed Opt 2010, 15:060501. 10.1117/1.3506043, 21198142.
24. Blackmore KM, Knight JA, Jong R, Lilge L. Assessing breast tissue density by transillumination breast spectroscopy (TIBS): an intermediate indicator of cancer risk. Br J Radiol 2007, 80:545-556. 10.1259/bjr/26858614, 17537757.
25. Blyschak K, Simick M, Jong R, Lilge L. Classification of breast tissue density by optical transillumination spectroscopy: optical and physiological effects governing predictive value. Med Phys 2004, 31:1398-1414. 10.1118/1.1738191, 15259643.
26. Tromberg BJ, Cerussi A, Shah N, Compton M, Durkin A, Hsiang D, Butler J, Mehta R. Imaging in breast cancer: diffuse optics in breast cancer: detecting tumors in pre-menopausal women and monitoring neoadjuvant chemotherapy. Breast Cancer Res 2005, 7:279-285. 10.1186/bcr1358, 1410753, 16457705.
27. Kukreti S, Cerussi A, Tromberg B, Gratton E. Intrinsic tumor biomarkers revealed by novel double-differential spectroscopic analysis of near-infrared spectra. J Biomed Opt 2007, 12:020509. 10.1117/1.2709701, 17477706.
28. Pham TH, Coquoz O, Fishkin JB, Anderson E, Tromberg BJ. Broad bandwidth frequency domain instrument for quantitative tissue optical spectroscopy. Rev Sci Instrum 2000, 71:2500-2513.
29. Bevilacqua F, Berger AJ, Cerussi AE, Jakubowski D, Tromberg BJ. Broadband absorption spectroscopy in turbid media by combined frequency-domain and steady-state methods. Appl Optics 2000, 39:6498-6507.
30. Jakubowski D, Bevilacqua F, Merritt S, Cerussi A, Tromberg B. Quantitative absorption and scattering spectra in thick tissues using broadband diffuse optical spectroscopy. Biomedical Optical Imaging 2009, 330-355. New York: Oxford University Press, Fujimoto JG, Farkas DL.
31. Cerussi AE, Jakubowski D, Shah N, Bevilacqua F, Lanning R, Berger AJ, Hsiang D, Butler J, Holcombe RF, Tromberg BJ. Spectroscopy enhances the information content of optical mammography. J Biomed Opt 2002, 7:60-71. 10.1117/1.1427050, 11818013.
32. Tanamai W, Chen C, Siavoshi S, Cerussi A. Diffuse optical spectroscopy measurements of healing in breast tissue after core biopsy: case study. J Biomed Opt 2009, 14:014024. 10.1117/1.3028012, 2872560, 19256712.
33. Kukreti S, Cerussi AE, Tanamai VW, Tromberg BJ, Rita M, David H, Gratton E. Intrinsic near-infrared spectroscopic biomarkers applied for evaluation of final pathological response to neaoadjuvant chemotherapy. Breast Cancer Res Treat 2007, 106:S218-S250.
34. Leproux A, Cerussi A, Tanamai VW, Durkin A, Compton M, Tromberg BJ, Gratton E. Impact of contralateral and ipsilateral reference tissue selection on self-referencing differential spectroscopy for breast cancer detection. J Biomed Opt 2011, 16:116019. 10.1117/1.3652711, 3223514, 22112124.
35. Roblyer D, Ueda S, Cerussi A, Tanamai W, Durkin A, Mehta R, Hsiang D, Butler JA, McLaren C, Chen W-P, Tromberg B. Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment. Proc Natl Acad Sci U S A 2011, 108:14626-14631. 10.1073/pnas.1013103108, 3167535, 21852577.
36. Kukreti S, Cerussi AE, Tanamai W, Hsiang D, Tromberg BJ, Gratton E. Characterization of metabolic differences between benign and malignant tumors: high-spectral-resolution diffuse optical spectroscopy. Radiology 2010, 254:277-284. 10.1148/radiol.09082134, 2797652, 20032159.
37. O'Sullivan T, Leproux A, Chen J-H, Bahri S, Matlock A, Roblyer D, McLaren C, Chen W-P, Cerussi A, Su M-Y, Tromberg BJ. Optical imaging correlates with magnetic resonance imaging breast density and reveals composition changes during neoadjuvant chemotherapy. Breast Cancer Res 2013, 15:R14. 10.1186/bcr3389, 3672664, 23433249.
38. Thomsen S, Tatman D. Physiological and pathological factors of human breast disease that can influence optical diagnosisa. Ann N Y Acad Sci 1998, 838:171-193. 10.1111/j.1749-6632.1998.tb08197.x, 9511805.
39. Pakalniskis MG, Wells WA, Schwab MC, Froehlich HM, Jiang S, Li Z, Tosteson TD, Poplack SP, Kaufman PA, Pogue BW, Paulsen KD. Tumor angiogenesis change estimated by using diffuse optical spectroscopic tomography: demonstrated correlation in women undergoing neoadjuvant chemotherapy for invasive breast cancer. Radiology 2011, 259:365-374. 10.1148/radiol.11100699, 3079119, 21406632.
40. Aboagye EO, Bhujwalla ZM. Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res 1999, 59:80-84.
41. Hilvo M, Denkert C, Lehtinen L, Müller B, Brockmöller S, Seppänen-Laakso T, Budczies J, Bucher E, Yetukuri L, Castillo S, Berg E, Nygren H, Sysi-Aho M, Griffin JL, Fiehn O, Loibl S, Richter-Ehrenstein C, Radke C, Hyötyläinen T, Kallioniemi O, Iljin K, Oresic M. Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression. Cancer Res 2011, 71:3236-3245. 10.1158/0008-5472.CAN-10-3894, 21415164.
42. Paran Y, Bendel P, Margalit R, Degani H. Water diffusion in the different microenvironments of breast cancer. NMR Biomed 2004, 17:170-180. 10.1002/nbm.882, 15229930.
43. Katz-Brull R, Lavin PT, Lenkinski RE. Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions. J Natl Cancer Inst 2002, 94:1197-1203. 10.1093/jnci/94.16.1197, 12189222.